glp 1 gip mechanism of action and Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary GLP-1 & GIP Agonists |

A Dietitian's Guide to Nutrition and GLP-1 Therapy Michael Glab MS, RD, LDN Nov 19, 2025 7 min read GLP-1 medications are currently all the rage in healthcare

Plan for challenging situations

Incretin-based therapiesreview of the physiology, pharmacology and emerging clinical experience

"The potential increase was smallfewer than one additional case per 2,000 GLP-1RA users, while these medications have very well-established benefits for diabetes, obesity, and heart and kidney health

Its two primary weaknesses are a pricing model gated behind intake data collection and a countdown timer at checkout that applies artificial urgency to a chronic medication decision